Starpharma

@Starpharma_ASX

Starpharma (ASX:SPL, US OTC:SPHRY) is an Australian biotech company, delivering meaningful patient outcomes through advanced dendrimer technology & innovation.

Melbourne starpharma.com Joined July 2013

524 Following 1.1K Followers 70 Posts

Latest posts 5

Starpharma @Starpharma_ASX Dec 22, 2025

CEO Cheryl Maley spoke with Arron Aatkar, Healthcare Analyst at the Edison Group, about Starpharma’s dendrimer technology, oncology programs, partnerships, and upcoming key milestones for investors. Check out the full update: investors.starpharma.com/activity-updat…

#SPL

Starpharma @Starpharma_ASX Feb 26, 2025

Our FY25 Half Year Report is here. Highlights include positive FDA feedback on DEP® SN38, advancing DEP® radiopharmaceuticals, and continued progress in our ongoing DEP® partnerships. Read the report at starpharma.com #Starpharma #biotech $SPL

Starpharma @Starpharma_ASX Feb 24, 2025

Ovarian cancer is one of the deadliest cancers in the world, with a 5-year survival rate of just 47%.
This #OvarianCancerAwarenessMonth, we're focused on advancing treatments that overcome the limitations of conventional therapies. Learn more: bit.ly/3QsqGJw

Starpharma @Starpharma_ASX Jan 20, 2025

Starpharma at #PepTalk 2025! 💡VP of Development & Regulatory Affairs, Dr. Jeremy Paull, delivered a presentation on our DEP® dendrimer platform at Cambridge Healthtech Institute’s 24th Annual PepTalk Conference last week. Read his presentation: bit.ly/3Ecca5v #SPL $SPL

Starpharma @Starpharma_ASX Jun 28, 2024

This week, we had the pleasure of hosting Dr. Mehdi Shahidi, CEO of Petalion Therapeutics and Venture Partner at Medicxi, and Shyam Masrani, Principal at Medicxi and Board representative of Petalion, at Starpharma.